| Literature DB >> 14552781 |
Brian Dyck1, Jessica Parker, Teresa Phillips, Lee Carter, Brian Murphy, Robin Summers, Julia Hermann, Tracy Baker, Mary Cismowski, John Saunders, Val Goodfellow.
Abstract
Incorporation of substituted phenyl piperazine privileged structures into a known MC4 specific dipeptoid consensus sequence resulted in a series of potent (EC(50)=24 nM) and selective MC4-R agonists. We report the SAR of this series of compounds using in vitro cAMP functional assays in cells transfected with the MC4 or other melancortin receptors.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14552781 DOI: 10.1016/s0960-894x(03)00796-0
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823